CN108079201A - 一种改善记忆力片及其制备方法 - Google Patents
一种改善记忆力片及其制备方法 Download PDFInfo
- Publication number
- CN108079201A CN108079201A CN201711374597.6A CN201711374597A CN108079201A CN 108079201 A CN108079201 A CN 108079201A CN 201711374597 A CN201711374597 A CN 201711374597A CN 108079201 A CN108079201 A CN 108079201A
- Authority
- CN
- China
- Prior art keywords
- memory piece
- preparation
- improve
- raw material
- piece
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000006872 improvement Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- 239000006071 cream Substances 0.000 claims description 15
- 235000019441 ethanol Nutrition 0.000 claims description 14
- 239000006286 aqueous extract Substances 0.000 claims description 13
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 235000019359 magnesium stearate Nutrition 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims description 5
- 239000007888 film coating Substances 0.000 claims description 5
- 238000009501 film coating Methods 0.000 claims description 5
- 238000007654 immersion Methods 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 238000005550 wet granulation Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- 235000012343 cottonseed oil Nutrition 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 20
- 208000026435 phlegm Diseases 0.000 abstract description 20
- 210000000952 spleen Anatomy 0.000 abstract description 18
- 241001165494 Rhodiola Species 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 241000208340 Araliaceae Species 0.000 abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 10
- 244000197580 Poria cocos Species 0.000 abstract description 10
- 235000008599 Poria cocos Nutrition 0.000 abstract description 10
- 235000008434 ginseng Nutrition 0.000 abstract description 10
- 230000001147 anti-toxic effect Effects 0.000 abstract description 7
- 239000000932 sedative agent Substances 0.000 abstract description 7
- 230000001624 sedative effect Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 6
- 230000006993 memory improvement Effects 0.000 abstract description 4
- 230000000144 pharmacologic effect Effects 0.000 abstract description 4
- 210000002216 heart Anatomy 0.000 description 27
- 210000003734 kidney Anatomy 0.000 description 16
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 235000015424 sodium Nutrition 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 239000000686 essence Substances 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 235000020985 whole grains Nutrition 0.000 description 4
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 3
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229930193974 gastrodin Natural products 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 240000005319 Sedum acre Species 0.000 description 1
- 235000014327 Sedum acre Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- -1 originally Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及医药技术领域,具体公开一种改善记忆力片及其制备方法。所述改善记忆力片,包括如下重量份数的原料组分:人参0.8‑1.2份;红景天1.5‑2.5份;远志1.8‑2.2份;茯苓3.5‑4.5份;天麻1.0‑2.0份。本发明提供的改善记忆力片,以人参、红景天、远志、茯苓、天麻为主要成分,充分利用上述各种中药原料的药性及功效,共同发挥益气补心健脾,祛痰化瘀通络、宁心安神益智的功效,且无任何配伍禁忌,共同达到辅助改善记忆的保健作用。
Description
技术领域
本发明涉及医药技术领域,尤其涉及一种改善记忆力片及其制备方法。
背景技术
记忆力减退属于中医“健忘”、“善忘”、“喜忘”的范畴。中医认为,“心藏神、肝藏魂、肺藏魄、脾藏意、肾藏智”,人的思维活动和五脏均有非常密切的关系。此外,“脑为元神之府”,脑髓盈满,则耳目聪明,精力充沛;脑髓空虚,可出现记忆减退。健忘的一大因素是为心肾亏虚,心血肾精不足难以濡养,心血涸、肾水竭从而心肾不交,久而久之就会导致健忘。巢元方认为,健忘是由过度虚劳引起的,五劳六极都可能引起机体出现健忘的症状,他在《诸病源候论》中论述:“心劳者,忽忽喜忘”。孙思邈认为人老体衰可导致肾阳虚衰,阴精不足,随着年龄的增长老年人的肾中阳气日渐亏少,肾阳不能上达于心,可导致健忘的产生。他还认为“六极”中的血极和精极与七情过度,即思虑体力过度劳损或情绪太激烈,会伤及心肾,从而导致健忘,与巢元方的理论相同。宋代朝廷组织编撰的《圣济总录》言“健忘之病,本于心虚”,其中认为心阳虚的睡眠质量不高导致记忆力下降,白天精神恍惚等障碍;心气血虚,精神状态混乱,也可以导致健忘。此外,七情所伤,久病入络,致瘀血内停,痰浊上蒙,亦可导致本病的发生。《伤寒杂病论》记载:“本有瘀血,故令人喜忘”,葛洪也认为心孔昏塞、神明不用是健忘产生的直接原因,其所著《肘后方》记载:“人心孔昏塞多忘喜误”。元代危亦林所著《世医得效方》有记载关于治疗健忘类方药,该书记载“痰迷心包,健忘失事,言语如凝”,并记载加味茯苓汤,专治痰迷心包健忘,开创了治疗健忘从痰论治的先河。明朝方剂大书《普济方》云:“夫健忘之病,本于心虚,血气衰少,精神昏馈,故志动乱而多忘也。盖心者,君主之官,神明出焉,苟为休惕思虑所伤,或愁忧过损,惊惧失志,皆致是疾。故曰:愁忧思虑则伤心,心伤则善忘。”表明了各种情志因素伤及心脾气血,从而导致健忘。袭廷贤在《寿世保元》一书中,专列有关“健忘”一门,认为心虚是健忘产生的根本原因,同时可兼它脏的虚损,其所列方剂包括养心安神、心肾同治等方式。中医认为健忘可由实证或虚证引起,虚证与心脾肾三脏虚损密切相关,实证则与瘀阻痰凝、脉络不通关系密切。故中医可以采用活血化瘀通络、益气补肾宁心等方法治疗健忘,达到改善记忆的效果。
总之,中医学认为记忆力减退发病机制为,思虑过度,劳伤心脾,则阴血耗损,生化乏源,脑失濡养;房事不节,精亏髓衰;或年高神减,五脏俱衰,均致脑失所养,神明失聪,令人健忘;情志不遂,肝郁气滞;若肝郁克脾,痰浊内生,上扰清窍;久病入络,瘀血内停,脑脉痹阻。
发明内容
针对现有人群因心脾气虚、痰瘀阻络、心神失养导致的记忆力减退的问题,本发明提供一种改善记忆力片及其制备方法。
为达到上述发明目的,本发明实施例采用了如下的技术方案:
一种改善记忆力片,包括如下重量份数的原料组分:
相对于现有技术,本发明提供的改善记忆力片,以人参、红景天、远志、茯苓、天麻为主要成分,充分利用上述各种中药原料的药性及功效,共同发挥益气补心健脾,祛痰化瘀通络、宁心安神益智的功效,且无任何配伍禁忌,共同达到辅助改善记忆的保健作用。
进一步地,本发明还提供所述改善记忆力片的制备方法。该制备方法,至少包括以下步骤:
(1)按照所述的原料配比称取各原料组分,用水浸泡,煎煮提取,得到水提液;
(2)将所述水提液进行减压浓缩处理,得到干膏;
(3)将所述干膏与微晶纤维素、糊精进行混料处理,得到混合粉,进行湿法制粒,得到预混颗粒;
(4)将所述预混颗粒与羧甲淀粉钠、硬脂酸镁进行混料处理后,经压片处理,得到素片;
(5)将所述素片进行包衣处理,得到包衣片,即改善记忆力片。
相对于现有技术,本发明提供的改善记忆力片的制备方法,工艺简单,操作方便,绿色环保,安全可靠,将人参、红景天、远志、茯苓、天麻中的有效成分浸提并浓缩到改善记忆力片中。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
本发明实施例提供一种改善记忆力片。该改善记忆力片,包括如下重量份数的原料组分:
优选地,所述的改善记忆力片,包括如下重量份数的原料组分:
根据配方比例进行配伍,充分利用上述各种中药原料的药性及功效,共同发挥益气补心健脾,祛痰化瘀通络、宁心安神益智的功效。
本发明改善记忆力片中有效成分的药材功效解析如下:
人参味甘、微苦,性微温。归脾、肺、心、肾经。功效大补元气、复脉固脱、补脾益肺、生津止渴。《神农本草经》言其“补五脏,安精神,定魂魄,止惊悸。”《药性论》载其“主五藏气不足,五劳七伤虚损。”《本草纲目》称其“治男妇一切虚证,发热自汗,眩晕头痛,反胃吐食。”可补益五脏之气,为补气的要药,有良好的补益心脾,安神增智的作用。
红景天甘、苦,平。归肺、心经。红景天甘,寒。归脾、肺经。20世纪60年代,前苏联科学家布列赫曼经研究发现红景天具有类似中医“扶正固本”的“适应原样作用”,为红景天的滋补作用提供了有力的科学依据。《中国药典》载其功能“益气活血,通脉平喘。主要用于气虚血瘀,胸痹心痛,倦怠气喘等。”我国其它红景天产区的居民视红景天为滋补佳品,享有“高原人参”的美誉。人参、红景天相伍,补益心脾之气,活血化瘀通络,宁心安神益智。用作君药。
远志苦、辛,温。归心、肾、肺经。功效安神益智、交通心肾、祛痰、消肿。最早记载于《神农本草经》,列为上品,并被视为养命要药,云其“主咳逆伤中,补不足,除邪气,利九窍,益智慧,耳目聪明,不忘,强志倍力”。《药性论》曰其“治心神健忘,坚壮阳道,主梦邪”。《药品化义》云:“远志,味辛重大雄,入心开窍,宣散之药。凡痰涎伏心,壅塞心窍,致心气实热,为昏聩神呆、语言蹇涩,为睡卧不宁,为恍惚惊怖,为健忘,为梦魇,为小儿客忤,暂以豁痰利窍,使心气开通,则神昏自宁也。”有良好的化痰开窍、交通心肾、安神益智的作用。
茯苓甘、淡,平。归心、肺、脾、肾经。功效利水渗湿、健脾、宁心。《神农本草经》载其:“主胸胁逆气,忧恚惊邪恐悸,心下结痛,寒热,烦满,咳逆,口焦舌干,利小便。久服安魂、养神、不饥、延年。”《世补斋医书》云其:“为治痰主药,痰之本,水也,茯苓可以行水。痰之动,湿也,茯苓又可行湿。”具有良好的健脾补中、渗湿祛痰、宁心安神之功。茯苓、远志相伍,增强健脾除湿化痰、宁心安神增智之功。同为臣药。
天麻甘、平。归肝经。功能祛风通络、平肝潜阳等,可用于头痛眩晕等。《日华子本草》记载,天麻能“助阳气补五劳七伤,通血脉,开窍”;《本草汇言》云其:“主头风,头痛,头晕虚旋,癫痫强痉,四肢挛急,语言不顺,一切中风,风痰。”说明天麻能平肝定眩、祛风通络,起到改善记忆的作用。用作佐药。
本发明实施例提供的改善记忆力片,以人参、红景天、远志、茯苓、天麻为主要成分,充分利用上述各种中药原料的药性及功效,共同发挥益气补心健脾,祛痰化瘀通络、宁心安神益智的功效,且无任何配伍禁忌,共同达到辅助改善记忆的保健作用。
本发明在提供该改善记忆力片的前提下,还进一步提供了该改善记忆力片的制备方法。
在一实施例中,该制备方法包括以下步骤:
(1)按照所述的原料配比称取各原料组分,用水浸泡,煎煮提取,得到水提液;
(2)将所述水提液进行减压浓缩处理,得到干膏;
(3)将所述干膏与微晶纤维素、糊精进行混料处理,得到混合粉,进行湿法制粒,得到预混颗粒;
(4)将所述预混颗粒与羧甲淀粉钠、硬脂酸镁进行混料处理后,经压片处理,得到素片;
(5)将所述素片进行包衣处理,得到包衣片,即改善记忆力片。
下面对上述制备方法做进一步的解释说明:
优选地,所述浸泡用水量与原料组分质量比为8-10:1,浸泡时间为2-3h;所述提取时间为2-3h,提取次数为2-3次,将中药原料组分中的有效成分如总皂苷、红景天苷、天麻素等充分浸提出来。
优选地,所述减压浓缩处理的真空度为-0.07MPa~-0.08MPa,温度为0~65℃,有助于将水提液浓缩得到干膏。
优选地,所述干膏与微晶纤维素、糊精、羧甲淀粉钠、硬脂酸镁进行过80目筛处理,使各成分混合的更加均匀。
优选地,所述湿法制粒的方法为加入原料组分质量30%的95%乙醇,采用20目筛制粒,于55~60℃干燥后,采用20目筛整粒,得到规整的预混颗粒。
优选地,所述包衣处理采用浓度为10%的薄膜包衣预混剂的乙醇溶液,所述乙醇为70%的乙醇,为素片进行包衣处理,防止素片的吸潮、软化、挥发等现象,为素片进行很好的保护作用。
优选地,所述素片为0.7g/片。
本方法制备工艺简单,操作方便,绿色环保,安全可靠,将人参、红景天、远志、茯苓、天麻中的有效成分总皂苷、红景天苷、天麻素浸提并浓缩到改善记忆力片中。
为了更好的说明本发明实施例提供的改善记忆力片及其制备方法,下面通过实施例做进一步的举例说明。
实施例1
改善记忆力片,包括如下重量份数的原料组分:
制备方法包括以下步骤:
(1)按照所述的原料配比称取各原料组分,用10倍重量份的水浸泡2h,煎煮提取2h,重复以上浸泡和提取2次,得到水提液200g;
(2)将所述水提液在真空度为-0.07MPa~-0.08MPa,温度为0~65℃条件下进行减压浓缩,得到干膏2.31g,包括人参0.22g、红景天0.44g、远志0.44g、茯苓0.88g、天麻0.33g,总出膏率为22%;
(3)将所述干膏与0.5g微晶纤维素、1g糊精进行混料处理,得到混合粉,3.82mL的95%乙醇,采用20目筛制粒,于55~60℃干燥后,采用20目筛整粒。得到预混颗粒3.81g;
(4)将所述预混颗粒与0.4g羧甲淀粉钠、0.1g硬脂酸镁进行混料处理后,经压片处理,得到0.7g/片的素片;
(5)将所述素片用浓度为10%的薄膜包衣预混剂的乙醇溶液进行包衣处理,得到包衣片,即改善记忆力片。
实施例2
改善记忆力片,包括如下重量份数的原料组分:
制备方法包括以下步骤:
(1)按照所述的原料配比称取各原料组分,用10倍重量份的水浸泡2h,煎煮提取2h,重复以上浸泡和提取2次,得到水提液200g;
(2)将所述水提液在真空度为-0.07MPa~-0.08MPa,温度为0~65℃条件下进行减压浓缩,得到干膏2.33g,总出膏率为22%;
(3)将所述干膏与0.5g微晶纤维素、1g糊精进行混料处理,得到混合粉,3.82mL的95%乙醇,采用20目筛制粒,于55~60℃干燥后,采用20目筛整粒。得到预混颗粒3.83g;
(4)将所述预混颗粒与0.4g羧甲淀粉钠、0.1g硬脂酸镁进行混料处理后,经压片处理,得到0.7g/片的素片;
(5)将所述素片用浓度为10%的薄膜包衣预混剂的乙醇溶液进行包衣处理,得到包衣片,即改善记忆力片。
实施例3
改善记忆力片,包括如下重量份数的原料组分:
制备方法包括以下步骤:
(1)按照所述的原料配比称取各原料组分,用10倍重量份的水浸泡2h,煎煮提取2h,重复以上浸泡和提取2次,得到水提液200g;
(2)将所述水提液在真空度为-0.07MPa~-0.08MPa,温度为0~65℃条件下进行减压浓缩,得到干膏2.29g,总出膏率为22%;
(3)将所述干膏与0.5g微晶纤维素、1g糊精进行混料处理,得到混合粉,3.82mL的95%乙醇,采用20目筛制粒,于55~60℃干燥后,采用20目筛整粒。得到预混颗粒3.79g;
(4)将所述预混颗粒与0.4g羧甲淀粉钠、0.1g硬脂酸镁进行混料处理后,经压片处理,得到0.7g/片的素片;
(5)将所述素片用浓度为10%的薄膜包衣预混剂的乙醇溶液进行包衣处理,得到包衣片,即改善记忆力片。
将通过上述实施例中的方法所得的改善记忆力片以90片/瓶进行装瓶,改善记忆力片为0.7g/片,服用时每日2次,每次3片,该改善记忆力片中的主要是有效成分总皂苷、红景天苷、天麻素共同发挥益气补心健脾,祛痰化瘀通络、宁心安神益智的功效,且无任何配伍禁忌,共同达到辅助改善记忆的保健作用。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换或改进等,均应包含在本发明的保护范围之内。
Claims (9)
1.一种改善记忆力片,其特征在于:包括如下重量份数的原料组分:
2.如权利要求1所述的改善记忆力片,其特征在于:包括如下重量份数的原料组分:
3.如权利要求1或2所述的改善记忆力片的制备方法,其特征在于:包括以下步骤:
(1)按照如权利要求1或2所述的原料配比称取各原料组分,用水浸泡,煎煮提取,得到水提液;
(2)将所述水提液进行减压浓缩处理,得到干膏;
(3)将所述干膏与微晶纤维素、糊精进行混料处理,得到混合粉,进行湿法制粒,得到预混颗粒;
(4)将所述预混颗粒与羧甲淀粉钠、硬脂酸镁进行混料处理后,经压片处理,得到素片;
(5)将所述素片进行包衣处理,得到包衣片,即改善记忆力片。
4.如权利要求3所述的改善记忆力片的制备方法,其特征在于:所述浸泡用水量与原料组分质量比为8-10:1,浸泡时间为2-3h;所述提取时间为2-3h,提取次数为2-3次。
5.如权利要求3所述的改善记忆力片的制备方法,其特征在于:所述减压浓缩处理的真空度为-0.07MPa~-0.08MPa,温度为0~65℃。
6.如权利要求3所述的改善记忆力片的制备方法,其特征在于:所述干膏与微晶纤维素、糊精、羧甲淀粉钠、硬脂酸镁进行过80目筛处理。
7.如权利要求3所述的改善记忆力片的制备方法,其特征在于:所述湿法制粒的方法为加入原料组分质量30%的95%乙醇,采用20目筛制粒,于55~60℃干燥后,采用20目筛整粒。
8.如权利要求3所述的改善记忆力片的制备方法,其特征在于:所述包衣处理采用浓度为10%的薄膜包衣预混剂的乙醇溶液,所述乙醇为70%的乙醇。
9.如权利要求3所述的改善记忆力片的制备方法,其特征在于:所述素片为0.7g/片。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711374597.6A CN108079201A (zh) | 2017-12-19 | 2017-12-19 | 一种改善记忆力片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711374597.6A CN108079201A (zh) | 2017-12-19 | 2017-12-19 | 一种改善记忆力片及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108079201A true CN108079201A (zh) | 2018-05-29 |
Family
ID=62177219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711374597.6A Pending CN108079201A (zh) | 2017-12-19 | 2017-12-19 | 一种改善记忆力片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108079201A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101486041B1 (ko) * | 2014-03-31 | 2015-01-23 | 주식회사 자연인 | 기억력 증진 한방 방향제 조성물 |
CN106563014A (zh) * | 2016-06-01 | 2017-04-19 | 谢晓亮 | 一种改善睡眠的中药组合物或保健品及其制备方法和用途 |
-
2017
- 2017-12-19 CN CN201711374597.6A patent/CN108079201A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101486041B1 (ko) * | 2014-03-31 | 2015-01-23 | 주식회사 자연인 | 기억력 증진 한방 방향제 조성물 |
CN106563014A (zh) * | 2016-06-01 | 2017-04-19 | 谢晓亮 | 一种改善睡眠的中药组合物或保健品及其制备方法和用途 |
Non-Patent Citations (1)
Title |
---|
马静遥,等: "改善认知功能障碍中药研究进展", 《中国中医药信息杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101032560B (zh) | 一种治疗睡眠障碍的中药组合物及制备方法 | |
CN102335330B (zh) | 一种治疗失眠的中药组合物 | |
CN104758591B (zh) | 一种治疗癫痫、抽动症和多动症的中药组合物 | |
CN103719491B (zh) | 一种黄精健脾润肺保健茶及其制备方法 | |
CN102302149A (zh) | 多参保健食品及其制备方法 | |
CN103719493B (zh) | 一种补脑益智的黄精保健茶及其制备方法 | |
CN106214964A (zh) | 安神的中药制剂 | |
CN105125946A (zh) | 一种清心除烦的栀子口服液及其制备方法 | |
CN104306678A (zh) | 一种治疗产后抑郁的中药制剂及制备方法 | |
WO2017152655A1 (zh) | 治疗广泛性焦虑症气血不足证型的中药制剂 | |
CN104225295B (zh) | 用于改善睡眠的组合物及其制备方法和应用 | |
CN103734853B (zh) | 一种改善记忆增强智力的饮料 | |
CN102846113B (zh) | 一种桑叶保健枕芯及其制备方法 | |
CN108079201A (zh) | 一种改善记忆力片及其制备方法 | |
CN101181486B (zh) | 一种治疗抑郁症的药物及其制备方法 | |
CN100418550C (zh) | 一种具有养心安神功效的中药及其制备方法 | |
CN111529636A (zh) | 一种治疗慢性失眠的中药组合物、中药制剂及其制备方法 | |
CN101856401B (zh) | 治疗失眠的外用中药组合物 | |
CN103142925A (zh) | 一种用于治疗冠心病的蒙药复方制剂 | |
CN104771614A (zh) | 一种治疗心胆气虚型神经衰弱的药物及其制备方法 | |
CN104523985A (zh) | 虫草养生中药酒及制备方法 | |
CN110179889B (zh) | 一种用于戒断海洛因毒瘾的中药组合物及其制备方法 | |
CN116688058B (zh) | 一种用于阳痿的黎药、其制备方法和应用 | |
CN102366443B (zh) | 一种治疗糖尿病的药物及其制备方法 | |
CN107233494A (zh) | 一种用于调节睡眠功能的中药配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200525 Address after: No.012, Jiazhuang administrative village, Jiazhuang Town, Mudan District, Heze City, Shandong Province Applicant after: Lan Xiang Address before: 101300, No. two, 1 road, Shunyi Park, Zhongguancun science and Technology Park, Beijing, Shunyi District Applicant before: ZHONGTAI YIJIA HEALTH TECHNOLOGY (BEIJING) Co.,Ltd. |